Product Images Nortriptyline Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Nortriptyline Hydrochloride NDC 61919-171 by Direct Rx, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image description - Label 10mg 30

image description - Label 10mg 30

The text contains information about a medication called Nortriptyline Hydrochloride. It comes in the form of 10mg capsules, with 30 capsules per bottle. The medication is commonly known by its generic name, Pamelor, and each capsule contains Nortriptyline HCL equivalent to 10mg. The rest of the text appears to be product identification codes and numbers and is not useful for understanding the medication.*

image description - Label 10mg 60

image description - Label 10mg 60

This appears to be a label of a medication container. The medication is Nortriptyline Hydrochloride, a generic version of Pamelor, and is available in a capsule form with a strength of 10mg, totaling 30 capsules. The medication's NDC number is 053381011, and it has an expiration date of February 2017. The label's lot number is not available.*

image description - Label25mg60

image description - Label25mg60

This is a product description of Nortriptyline Hydrochloride capsules, a generic equivalent for Pamelor. Each capsule contains 25mg of nortriptyline HCL. The total quantity per container is 60 capsules.*

image description - STRUCTUALFORMULA

image description - STRUCTUALFORMULA

image description - TABLE1

image description - TABLE1

The text describes a table titled "Table 1" that contains information on the effects of drugs compared to placebo on the incidence of suicidality in patients of different age groups. The table shows the age ranges and the drug-placebo difference in the number of cases of suicidality per 1000 patients treated. For patients under 18 years old, there were 14 additional cases compared to placebo, while for patients aged 18-24 there were 5 additional cases. However, for patients aged 25-64, there were fewer cases of suicidality compared to placebo, with 1 fewer case for those aged 25-64 and 6 fewer cases for those aged 65 or older.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.